| Q28550535 | A Survey on Use of Rapid Tests and Tuberculosis Diagnostic Practices by Primary Health Care Providers in South Africa: Implications for the Development of New Point-of-Care Tests |
| Q36855346 | A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis |
| Q36745641 | Accurate Detection of Rifampicin-Resistant Mycobacterium Tuberculosis Strains |
| Q38562541 | Advances in Diagnostic Assays for Tuberculosis |
| Q40142831 | Combination of commercially available molecular assays and culture based methods in diagnosis of tuberculosis and drug resistant tuberculosis. |
| Q64269485 | Comparison of Quantamatrix Multiplexed Assay Platform and GenoType MTBDR Assay Using Smear-Positive Sputum Specimens From Patients With Multidrug- Resistant/Extensively Drug-Resistant Tuberculosis in South Korea |
| Q61807571 | Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation |
| Q92657500 | Deciphering Within-Host Microevolution of Mycobacterium tuberculosis through Whole-Genome Sequencing: the Phenotypic Impact and Way Forward |
| Q94559335 | European Union training programme for tuberculosis laboratory experts: design, contribution and future direction |
| Q28551226 | External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study |
| Q38248018 | Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation |
| Q26752616 | Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review |
| Q34340287 | KvarQ: targeted and direct variant calling from fastq reads of bacterial genomes. |
| Q36734934 | MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis. |
| Q49332451 | Molecular Diagnosis of Tuberculosis. |
| Q35222224 | Molecular diagnostics |
| Q37722890 | Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosis |
| Q35757756 | Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples |
| Q39721362 | Rapid detection of MDR-Mycobacterium tuberculosis using modified PCR-SSCP from clinical Specimens |
| Q55366967 | Rapid molecular assays for detection of tuberculosis. |
| Q39014173 | Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis |
| Q40311802 | Severe Tuberculosis Requiring Intensive Care: A Descriptive Analysis |
| Q26749040 | The implications of whole-genome sequencing in the control of tuberculosis |
| Q52644255 | Time-and-motion tool for the assessment of working time in tuberculosis laboratories: a multicentre study. |
| Q38360615 | Tuberculous meningitis: advances in diagnosis and treatment. |
| Q41585779 | Utility of propidium monoazide viability assay as a biomarker for a tuberculosis disease |
| Q64117158 | Whole genome sequencing for drug resistance determination in Mycobacterium tuberculosis |
| Q36084640 | Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study |
| Q41677504 | Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria. |
Search more.